Skip to main content
. 2014 Dec 19;3:31. doi: 10.1186/2162-3619-3-31

Table 2.

Efficacy of rituximab and 2-CdA in the WSU-WM-SCID xenograft model

Agent Dose/(mg/kg), schedule Route Mice T/C (%) T-C Days Log 10 kill Cure
Control Diluent, QD × 5 i.v. 8 100 0 0 0/8
Rituximab 150 mg, QD × 5 i.v. 8 30 13 1.9 0/8
2-CdA 30 mg, QD × 5 s.c. 8 36.9 14 1.33 0/8
(RTX + 2-CdA) (150 + 30),QD × 5 (i.v. + s.c.)
Diluent Diluent, QD × 5 i.v. 8 16.9 N/A N/A 8/8
(RTX + 2-CdA) (150 + 30),QD × 5 (i.v. + s.c.)